159 related articles for article (PubMed ID: 35302849)
1. Reconstructing codependent cellular cross-talk in lung adenocarcinoma using REMI.
Yu A; Li Y; Li I; Ozawa MG; Yeh C; Chiou AE; Trope WL; Taylor J; Shrager J; Plevritis SK
Sci Adv; 2022 Mar; 8(11):eabi4757. PubMed ID: 35302849
[TBL] [Abstract][Full Text] [Related]
2. A human lung tumor microenvironment interactome identifies clinically relevant cell-type cross-talk.
Gentles AJ; Hui AB; Feng W; Azizi A; Nair RV; Bouchard G; Knowles DA; Yu A; Jeong Y; Bejnood A; Forgó E; Varma S; Xu Y; Kuong A; Nair VS; West R; van de Rijn M; Hoang CD; Diehn M; Plevritis SK
Genome Biol; 2020 May; 21(1):107. PubMed ID: 32381040
[TBL] [Abstract][Full Text] [Related]
3. A systematic evaluation of the computational tools for ligand-receptor-based cell-cell interaction inference.
Wang S; Zheng H; Choi JS; Lee JK; Li X; Hu H
Brief Funct Genomics; 2022 Sep; 21(5):339-356. PubMed ID: 35822343
[TBL] [Abstract][Full Text] [Related]
4. Cell-to-cell interaction analysis of prognostic ligand-receptor pairs in human pancreatic ductal adenocarcinoma.
Suzuki SR; Kuno A; Ozaki H
Biochem Biophys Rep; 2021 Dec; 28():101126. PubMed ID: 34522794
[TBL] [Abstract][Full Text] [Related]
5. Integrating bulk-RNA sequencing and single-cell sequencing analyses to characterize adenosine-enriched tumor microenvironment landscape and develop an adenosine-related prognostic signature predicting immunotherapy in lung adenocarcinoma.
Han T; Wu J; Liu Y; Zhou J; Miao R; Guo J; Xu Z; Xing Y; Bai Y; Hu D
Funct Integr Genomics; 2024 Jan; 24(1):19. PubMed ID: 38265702
[TBL] [Abstract][Full Text] [Related]
6. T cell-related prognostic risk model and tumor immune environment modulation in lung adenocarcinoma based on single-cell and bulk RNA sequencing.
Zhang J; Liu X; Huang Z; Wu C; Zhang F; Han A; Stalin A; Lu S; Guo S; Huang J; Liu P; Shi R; Zhai Y; Chen M; Zhou W; Bai M; Wu J
Comput Biol Med; 2023 Jan; 152():106460. PubMed ID: 36565482
[TBL] [Abstract][Full Text] [Related]
7. Elaboration and validation of a prognostic signature associated with disulfidoptosis in lung adenocarcinoma, consolidated with integration of single-cell RNA sequencing and bulk RNA sequencing techniques.
He D; Tang H; Yang X; Liu X; Zhang Y; Shi J
Front Immunol; 2023; 14():1278496. PubMed ID: 37965333
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics analysis and single-cell RNA sequencing: elucidating the ubiquitination pathways and key enzymes in lung adenocarcinoma.
Lu T; Xu R; Wang C; Zhou X; Parra-Medina R; Díaz-Peña R; Peng B; Zhang L
J Thorac Dis; 2023 Jul; 15(7):3885-3907. PubMed ID: 37559628
[TBL] [Abstract][Full Text] [Related]
9. Integrative Analysis of Single-Cell and Bulk RNA Sequencing Reveals Prognostic Characteristics of Macrophage Polarization-Related Genes in Lung Adenocarcinoma.
Mi K; Zeng L; Chen Y; Yang S
Int J Gen Med; 2023; 16():5031-5050. PubMed ID: 37942473
[TBL] [Abstract][Full Text] [Related]
10. Construction of RNA Methylation Modification-immune-related lncRNA Molecular Subtypes and Prognostic Scoring System in Lung Adenocarcinoma.
Wang J; Shu J
Curr Med Chem; 2024; 31(12):1539-1560. PubMed ID: 37680151
[TBL] [Abstract][Full Text] [Related]
11. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Li N; Li Y; Zheng P; Zhan X
Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
[TBL] [Abstract][Full Text] [Related]
12. Ligand-receptor interaction atlas within and between tumor cells and T cells in lung adenocarcinoma.
Chen Z; Yang X; Bi G; Liang J; Hu Z; Zhao M; Li M; Lu T; Zheng Y; Sui Q; Yang Y; Zhan C; Jiang W; Wang Q; Tan L
Int J Biol Sci; 2020; 16(12):2205-2219. PubMed ID: 32549766
[No Abstract] [Full Text] [Related]
13. Molecular subtyping for lung adenocarcinoma and a novel prognostic model based on ligand-receptor pairs.
Li D; Ma X; Ou S
Adv Med Sci; 2022 Sep; 67(2):316-327. PubMed ID: 36054998
[TBL] [Abstract][Full Text] [Related]
14. Single-cell analysis reveals exosome-associated biomarkers for prognostic prediction and immunotherapy in lung adenocarcinoma.
Lin S; Zhou S; Han X; Yang Y; Zhou H; Chang X; Zhou Y; Ding Y; Lin H; Hu Q
Aging (Albany NY); 2023 Oct; 15(20):11508-11531. PubMed ID: 37878007
[TBL] [Abstract][Full Text] [Related]
15. High-resolution transcriptomics analysis of CXCL13
Zeng L; Chen X; Cui J; Zhang L; Li L; Yin C; Chen X; Sun J
J Thorac Dis; 2024 Jan; 16(1):201-214. PubMed ID: 38410612
[TBL] [Abstract][Full Text] [Related]
16. Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches.
Jiang J; Zhang Y; Wang J; Yang X; Ren X; Huang H; Wang J; Lu J; Zhong Y; Lin Z; Lin X; Jia Y; Lin S
PeerJ; 2023; 11():e16166. PubMed ID: 37790630
[TBL] [Abstract][Full Text] [Related]
17. Single-cell RNA sequencing integrated with bulk RNA sequencing analysis identifies a tumor immune microenvironment-related lncRNA signature in lung adenocarcinoma.
Ren Y; Wu R; Li C; Liu L; Li L; Weng S; Xu H; Xing Z; Zhang Y; Wang L; Liu Z; Han X
BMC Biol; 2024 Mar; 22(1):69. PubMed ID: 38519942
[TBL] [Abstract][Full Text] [Related]
18. An integrated bioinformatic analysis of bulk and single-cell sequencing clarifies immune microenvironment and metabolic profiles of lung adenocarcinoma to predict immunotherapy efficacy.
Li M; Zhou B; Zheng C
Front Cell Dev Biol; 2023; 11():1163314. PubMed ID: 37091977
[TBL] [Abstract][Full Text] [Related]
19. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Zuo S; Wei M; Wang S; Dong J; Wei J
Front Immunol; 2020; 11():1218. PubMed ID: 32714316
[No Abstract] [Full Text] [Related]
20. Identification of a novel snoRNA expression signature associated with overall survival in patients with lung adenocarcinoma: A comprehensive analysis based on RNA sequencing dataset.
Zhang L; Xin M; Wang P
Math Biosci Eng; 2021 Sep; 18(6):7837-7860. PubMed ID: 34814278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
